Estradiol Valerate

CAS 979-32-8 7 current records 2 historicalSmall Molecule

Who holds supplier records for Estradiol Valerate? 7 organisations hold a current record for Estradiol Valerate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Netherlands (1), Germany (1), France (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Estradiol Valerate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/estradiol-valerate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Estradiol Valerate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Netherlands1Germany1France1Italy1Country not recorded for 1
  • ASPEN OSS BV
    Active DMF 12268 · latest filing Dec 1996
    NetherlandsCEP Company GMP cert on record
  • Bayer AG
    Active DMF 3379 · latest filing Nov 1978
    GermanyCEP Company GMP cert on record
  • VALDEPHARM
    Active DMF 23948 · latest filing Jul 2010
    FranceCEP Company GMP cert on record
  • Lupin Limited
    Active DMF 25854 · latest filing Mar 2012
    India Company GMP cert on record
  • STEROID SPA
    Active DMF 39594 · latest filing Mar 2024
    Italy Company GMP cert on record
  • SHAKTI LIFESCIENCE PRIVATE LIMITED
    IndiaCEP
  • ZHEJIANG XIANJU PHARMACEUTICAL CO LTD
    CEP
Need Estradiol Valerate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Estradiol Valerate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
VALDEPHARM Val de ReuilFR
CEP 2010-224 - Rev 06
Estradiol valerate, Micronised fine, non-micronised
Aug 2025Inspected Dec 2024
France
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2023-362 - Rev 00
Estradiol valerate, Non-micronised and micronised
Jul 2025—
ASPEN OSS B.V. OssNL
CEP 2009-171 - Rev 02
Estradiol valerate
Apr 2025Inspected Oct 2025
Netherlands
BAYER AG LeverkusenDE
CEP 2006-166 - Rev 04
Estradiol valerate, Micronised (micro 20)
Oct 2024—
SHAKTI LIFESCIENCE PRIVATE LIMITED MumbaiIN
CEP 2022-351 - Rev 00
Estradiol valerate
Sept 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Estradiol Valerate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Hungary · Inactive DMF 24553 · filed Jan 2011
  • ROUSSELL UCLAF
    Inactive DMF 3072 · filed Nov 1977

Overview

Estradiol Valerate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1511).

Chemical identity

IUPAC name
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate
Canonical SMILES
CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C
InChIKey
RSEPBGGWRJCQGY-RBRWEJTLSA-N
Synonyms
.beta.-estradiol 17-valerate, Climaval, Deladumone, Delestrogen, Estradiol 17-valerate, Estradiol valerate, Estradiol valerate component of ditate-ds, Estradiol valerate component of natazia, Femtab, NSC-17590, Progynon depot, Progynon-depot-10

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Estrogen
Mechanism of action
Estrogen Receptor Agonists
Chemical structure
Estradiol Congeners

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Estradiol Valerate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Estradiol Valerate: ASPEN OSS BV (Netherlands), Bayer AG (Germany), VALDEPHARM (France), Lupin Limited (India), STEROID SPA (Italy), SHAKTI LIFESCIENCE PRIVATE LIMITED (India) and ZHEJIANG XIANJU PHARMACEUTICAL CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Estradiol Valerate Drug Master Files are active?

ASPEN OSS BV (DMF 12268), Bayer AG (DMF 3379), VALDEPHARM (DMF 23948), Lupin Limited (DMF 25854) and STEROID SPA (DMF 39594). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Estradiol Valerate records mean?

2 organisations have only inactive Type II DMFs for Estradiol Valerate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Estradiol Valerate have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Estradiol Valerate on the EDQM register, including VALDEPHARM Val de Reuil (FR), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), ASPEN OSS B.V. Oss (NL), BAYER AG Leverkusen (DE) and SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Estradiol Valerate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Estradiol Valerate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.